Impulse Biomedical
Impulse Biomedical is the force behind breakthrough devices that are reshaping emergency care. Their flagship products include the Easy Squeezy, an affordable and easy-to-use asthma inhaler that empowers patients to manage asthma more effectively, and the ZiBiPen, the world’s first reloadable epinephrine auto-injector.
Location: South Africa
Website: https://www.impulsebiomed.com/
Sector: Healthcare
Funding Stage: Venture Round Venture Round Venture Round
Total Funding ($m): $1.6M
# of Founders: 2
Founding Year: 2017
Funding Year: 2025
Status: Active
| Year | Amount | Stage | Investors |
|---|---|---|---|
| 2021 | $1.5m | Venture Round | Futuregrowth Asset Management and others |
| 2022 | $0.1m | Venture Round | Launch Africa |
| 2025 | $Undisclosedm | Venture Round | E Squared Investments and ANZA Capital |
 | Co-Founder & CEO  |
Venture Round $1.5m
Futuregrowth Asset Management and others
Venture Round $0.1m
Launch Africa
Venture Round $Undisclosedm
E Squared Investments and ANZA Capital